These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 36658411

  • 1. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC, Souvatzoglou M, Paraskevas GP, Chalioti M, Stefanis L, Kapaki E.
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [Abstract] [Full Text] [Related]

  • 2. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S, Van De Ville D, Nicastro N, Garibotto V, Burkhard PR, Haller S.
    Neuroimage Clin; 2016 May; 12():234-40. PubMed ID: 27489771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
    Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE.
    Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS.
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
    Chen QS, Li XY, Li L, Lu JY, Sun YM, Liu FT, Zuo CT, Wang J.
    Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
    [Abstract] [Full Text] [Related]

  • 9. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, Meucci N, Canesi M, Mariani C, Pezzoli G, Gerundini P.
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [Abstract] [Full Text] [Related]

  • 10. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
    Kaasinen V, Kankare T, Joutsa J, Vahlberg T.
    J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.
    Joling M, Vriend C, van den Heuvel OA, Raijmakers PGHM, Jones PA, Berendse HW, Booij J.
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [Abstract] [Full Text] [Related]

  • 14. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP, Stamelou M.
    Int Rev Neurobiol; 2017 Jul; 134():1285-1301. PubMed ID: 28805573
    [Abstract] [Full Text] [Related]

  • 15. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F, Barron DS, Tantiwongkosi B, Fox P.
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O.
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [Abstract] [Full Text] [Related]

  • 19. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C, Acarer A, Guneyli S, Akyuz E, Aydin E, Colakoglu Z, Kitis O, Calli MC.
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.